Microvascular dysfunction in diabetes mellitus and cardiometabolic disease
WB Horton, EJ Barrett - Endocrine reviews, 2021 - academic.oup.com
This review takes an inclusive approach to microvascular dysfunction in diabetes mellitus
and cardiometabolic disease. In virtually every organ, dynamic interactions between the …
and cardiometabolic disease. In virtually every organ, dynamic interactions between the …
Hypertension management in patients with cardiovascular comorbidities
Arterial hypertension is a leading cause of death globally. Due to ageing, the rising
incidence of obesity, and socioeconomic and environmental changes, its incidence …
incidence of obesity, and socioeconomic and environmental changes, its incidence …
[PDF][PDF] 2013 ESH/ESC Guidelines for the management of arterial hypertension
G Mancia, R Fagard, K Narkiewicz… - Arterial …, 2013 - journals.viamedica.pl
Wytyczne dotyczące nadciśnienia tętniczego opublikowane w 2013 r. przez Europejskie
Towarzystwo Nadciśnienia Tętniczego (ESH) i Europejskie Towarzystwo Kardiologiczne …
Towarzystwo Nadciśnienia Tętniczego (ESH) i Europejskie Towarzystwo Kardiologiczne …
SGLT2 inhibitor–induced sympathoinhibition: a novel mechanism for cardiorenal protection
LY Herat, AL Magno, C Rudnicka, J Hricova… - Basic to Translational …, 2020 - jacc.org
Recent clinical trial data suggest a cardiorenal protective effect of sodium glucose
cotransporter 2 (SGLT2) inhibition. We demonstrate that chemical denervation in neurogenic …
cotransporter 2 (SGLT2) inhibition. We demonstrate that chemical denervation in neurogenic …
Mechanisms of diabetic complications
It is increasingly apparent that not only is a cure for the current worldwide diabetes epidemic
required, but also for its major complications, affecting both small and large blood vessels …
required, but also for its major complications, affecting both small and large blood vessels …
Relevance of sympathetic nervous system activation in obesity and metabolic syndrome
AA Thorp, MP Schlaich - Journal of diabetes research, 2015 - Wiley Online Library
Sympathetic tone is well recognised as being implicit in cardiovascular control. It is less
readily acknowledged that activation of the sympathetic nervous system is integral in energy …
readily acknowledged that activation of the sympathetic nervous system is integral in energy …
Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study
Background Renal denervation (RDN) with radiofrequency ablation substantially reduces
blood pressure in patients with treatment-resistant hypertension. We assessed the long-term …
blood pressure in patients with treatment-resistant hypertension. We assessed the long-term …
The role of the autonomic nervous system in the pathophysiology of obesity
D Guarino, M Nannipieri, G Iervasi, S Taddei… - Frontiers in …, 2017 - frontiersin.org
Obesity is reaching epidemic proportions globally and represents a major cause of
comorbidities, mostly related to cardiovascular disease. The autonomic nervous system …
comorbidities, mostly related to cardiovascular disease. The autonomic nervous system …
New approaches in the treatment of hypertension
S Oparil, RE Schmieder - Circulation research, 2015 - Am Heart Assoc
Hypertension is the most common modifiable risk factor for cardiovascular disease and
death, and lowering blood pressure with antihypertensive drugs reduces target organ …
death, and lowering blood pressure with antihypertensive drugs reduces target organ …
Type 2 diabetes mellitus and hypertension: an update
G Lastra, S Syed, LR Kurukulasuriya… - Endocrinology and …, 2014 - endo.theclinics.com
Hypertension (HTN) is present in more than 50% of patients with diabetes mellitus (DM) and
contributes significantly to both microvascular and macrovascular disease in DM (Fig. 1). 1 …
contributes significantly to both microvascular and macrovascular disease in DM (Fig. 1). 1 …